Publications
5539 Results
- Journal / Conference
- American Society of Clinical Oncology Gastrointestinal Cancers Symposium #25
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0101
SWOG 0101: Evaluation of gemcitabine and irinotecan in esophageal cancer
- Journal / Conference
- Cancer 100(8):1699-1704
- Year
- 2004
- Research Committee(s)
- Melanoma
- Study Number(s)
- S9804
A phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:400, (#4579)
- Year
- 2004
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
Quality of Life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:382 (#4505)
- Year
- 2004
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): data from Southwest Oncology Group Study S9916
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:2 (#3)
- Year
- 2004
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9916
SWOG 99-16: randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone (M)/prednisone (p) in men with androgen-independent prostate cancer (AIPCA)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:707 (#7501)
- Year
- 2004
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9035
Significant impact of HLA class I allele expression on outcome in melanoma patients treated with an allogeneic melanoma cell lysate vaccine. Final analysis of SWOG-9035.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:567 (#6546)
- Year
- 2004
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9208
Predictors of vitality (energy/fatigue) in early stage hodgkin's disease (HD): results from Southwest Oncology Group (SWOG) study 9133
- Journal / Conference
- Proc of the American Society of Clincial Oncology 23:852 (#9585)
- Year
- 2004
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9252 (INT-0115) (EST-3590) (RTOG 91-05) (NCCTG-91-24-51) (CALGB-9393)
EGFr dinucleotide repeat polymorphism in non-small cell lung cancer
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:107 (#1500)
- Year
- 2004
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9402
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: initial report of RTOG 94-02
- Journal / Conference
- Proc of the American Society of Clinical Oncology 23:616 (#7007)
- Year
- 2004
- Research Committee(s)
- Lung
- Study Number(s)
- S0003